Does PROBUCOL Cause Type iia hyperlipidaemia? 56 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Type iia hyperlipidaemia have been filed in association with PROBUCOL. This represents 35.7% of all adverse event reports for PROBUCOL.
56
Reports of Type iia hyperlipidaemia with PROBUCOL
35.7%
of all PROBUCOL reports
55
Deaths
12
Hospitalizations
How Dangerous Is Type iia hyperlipidaemia From PROBUCOL?
Of the 56 reports, 55 (98.2%) resulted in death, 12 (21.4%) required hospitalization.
Is Type iia hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PROBUCOL. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does PROBUCOL Cause?
Disease progression (57)
Liver injury (17)
Cholecystitis acute (14)
Abdominal pain (13)
Hypotension (13)
Nausea (13)
Pleural effusion (13)
Pneumonia (7)
Drug ineffective (5)
Therapeutic product effect incomplete (5)
What Other Drugs Cause Type iia hyperlipidaemia?
ATORVASTATIN (67)
EZETIMIBE (67)
EVOLOCUMAB (66)
ROSUVASTATIN (63)
SIMVASTATIN (63)
LOMITAPIDE (59)
LOVASTATIN (56)
IMPLITAPIDE (49)
CAFFEINE\PROCAINE (10)
TOCILIZUMAB (8)
Which PROBUCOL Alternatives Have Lower Type iia hyperlipidaemia Risk?
PROBUCOL vs PROCAINAMIDE
PROBUCOL vs PROCAINE
PROBUCOL vs PROCARBAZINE
PROBUCOL vs PROCHLORPERAZINE
PROBUCOL vs PROCHLORPERAZINE EDISYLATE